English

Adams Respiratory Therapeutics, Inc.

EDGAR

Quarterly report (10-Q) · filed 2007-11-09

13 filing records in this dataset, filed from 2005-09-28 to 2007-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

110 million USD

2007-09-30 · USD

Exact inputs and evidence

Revenue: 109976000 USD Source

Net margin

26.59%

2007-09-30 · %

Exact inputs and evidence

Net Income: 29239000 USD Source
Revenue: 109976000 USD Source

Operating cash flow

-14.9 million USD

2007-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14893000 USD Source

Free cash flow

-16.5 million USD

2007-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14893000 USD Source
Capital Expenditure: 1559000 USD Source

Cash and cash equivalents: 32.8 million USD 2007-09-30 Source
Exact value

32780000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

351 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Revenue: 110576000 USD · 2006-10-01 – 2006-12-31 Source
Revenue: 84024000 USD · 2007-01-01 – 2007-03-31 Source
Revenue: 331603000 USD · 2006-07-01 – 2007-06-30 Source
Revenue: 284742000 USD · 2006-07-01 – 2007-03-31 Source
Revenue: 109976000 USD · 2007-07-01 – 2007-09-30 Source

Net income

43.6 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Net income: 12523000 USD · 2006-10-01 – 2006-12-31 Source
Net income: 2864000 USD · 2007-01-01 – 2007-03-31 Source
Net income: 30529000 USD · 2006-07-01 – 2007-06-30 Source
Net income: 31565000 USD · 2006-07-01 – 2007-03-31 Source
Net income: 29239000 USD · 2007-07-01 – 2007-09-30 Source

Operating cash flow

13.6 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Operating cash flow: -12926000 USD · 2006-07-01 – 2006-12-31 Source
Operating cash flow: -22227000 USD · 2006-07-01 – 2006-09-30 Source
Operating cash flow: 2466000 USD · 2006-07-01 – 2007-03-31 Source
Operating cash flow: -12926000 USD · 2006-07-01 – 2006-12-31 Source
Operating cash flow: 6266000 USD · 2006-07-01 – 2007-06-30 Source
Operating cash flow: 2466000 USD · 2006-07-01 – 2007-03-31 Source
Operating cash flow: -14893000 USD · 2007-07-01 – 2007-09-30 Source

Capital expenditure

8.72 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Capital expenditure: 10066000 USD · 2006-07-01 – 2006-12-31 Source
Capital expenditure: 8151000 USD · 2006-07-01 – 2006-09-30 Source
Capital expenditure: 12946000 USD · 2006-07-01 – 2007-03-31 Source
Capital expenditure: 10066000 USD · 2006-07-01 – 2006-12-31 Source
Capital expenditure: 15314000 USD · 2006-07-01 – 2007-06-30 Source
Capital expenditure: 12946000 USD · 2006-07-01 – 2007-03-31 Source
Capital expenditure: 1559000 USD · 2007-07-01 – 2007-09-30 Source

Free cash flow

4.88 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Operating cash flow: -12926000 USD · 2006-07-01 – 2006-12-31 Source
Operating cash flow: -22227000 USD · 2006-07-01 – 2006-09-30 Source
Operating cash flow: 2466000 USD · 2006-07-01 – 2007-03-31 Source
Operating cash flow: -12926000 USD · 2006-07-01 – 2006-12-31 Source
Operating cash flow: 6266000 USD · 2006-07-01 – 2007-06-30 Source
Operating cash flow: 2466000 USD · 2006-07-01 – 2007-03-31 Source
Operating cash flow: -14893000 USD · 2007-07-01 – 2007-09-30 Source
Capital expenditure: 10066000 USD · 2006-07-01 – 2006-12-31 Source
Capital expenditure: 8151000 USD · 2006-07-01 – 2006-09-30 Source
Capital expenditure: 12946000 USD · 2006-07-01 – 2007-03-31 Source
Capital expenditure: 10066000 USD · 2006-07-01 – 2006-12-31 Source
Capital expenditure: 15314000 USD · 2006-07-01 – 2007-06-30 Source
Capital expenditure: 12946000 USD · 2006-07-01 – 2007-03-31 Source
Capital expenditure: 1559000 USD · 2007-07-01 – 2007-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-11-09.

Financial data available through: 2007-06-30.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2007-06-30
operating income: No compatible figures in this window
Net income: 5 of 11 periods available· newest 2007-06-30
Operating cash flow: 5 of 11 periods available· newest 2007-06-30
Capital expenditure: 5 of 11 periods available· newest 2007-06-30
Total assets: 4 of 11 periods available· newest 2007-06-30
Total liabilities: 4 of 11 periods available· newest 2007-06-30
Current assets: 4 of 11 periods available· newest 2007-06-30
Current liabilities: 4 of 11 periods available· newest 2007-06-30
Cash and cash equivalents: 5 of 11 periods available· newest 2007-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+38.7%

Prior period

USD 239.11 million

2005-07-01 – 2006-06-30
Current period

USD 331.6 million

2006-07-01 – 2007-06-30

Exact inputs and evidence

331603000 − 239105000 = 92498000 USD

239105000 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
331603000 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Year-over-year change in Revenue: 92498000 USD Concept: fundies:Revenue Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 331603000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#26966 Input fundies:Revenue: 239105000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#26966
The citation records this snapshot. The page link may show a newer release later.
Net income
-34.1%

Prior period

USD 46.35 million

2005-07-01 – 2006-06-30
Current period

USD 30.53 million

2006-07-01 – 2007-06-30

Exact inputs and evidence

30529000 − 46351000 = -15822000 USD

46351000 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
30529000 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Year-over-year change in Net income: -15822000 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 30529000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#31681 Input fundies:NetIncome: 46351000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#31681
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-87.4%

Prior period

USD 49.75 million

2005-07-01 – 2006-06-30
Current period

USD 6.27 million

2006-07-01 – 2007-06-30

Exact inputs and evidence

6266000 − 49752000 = -43486000 USD

49752000 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
6266000 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Year-over-year change in Operating cash flow: -43486000 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 6266000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 Input fundies:OperatingCashFlow: 49752000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+124.8%

Prior period

USD 6.81 million

2005-07-01 – 2006-06-30
Current period

USD 15.31 million

2006-07-01 – 2007-06-30

Exact inputs and evidence

15314000 − 6812000 = 8502000 USD

6812000 USD · 2005-07-01 – 2006-06-30
Inspect prior input Prior source
15314000 USD · 2006-07-01 – 2007-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Year-over-year change in Capital expenditure: 8502000 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 15314000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 Input fundies:CapitalExpenditure: 6812000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2006-07-01 – 2007-06-30

Revenue USD 331.6 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income USD 30.53 million 9.2% of revenue

Cash

Operating cash flow USD 6.27 million 1.9% of revenue
Capital expenditure USD 15.31 million 4.6% of revenue
Free cash flow Derived −USD 9.05 million −2.7% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2002-07-01 – 2003-06-30	14038000	Unavailable	Unavailable	Unavailable	-22638000	-14016000 Derived	Source 2002-07-01 – 2003-06-30: 14038000 USD Inspect Revenue Open source 2002-07-01 – 2003-06-30: -22638000 USD Inspect Net Income Open source 2002-07-01 – 2003-06-30: -13614000 USD Inspect Operating Cash Flow Open source 2002-07-01 – 2003-06-30: 402000 USD Inspect Capital Expenditure Open source
2004 2003-07-01 – 2004-06-30	61295000	Unavailable	Unavailable	Unavailable	35826000	25223000 Derived	Source 2003-07-01 – 2004-06-30: 61295000 USD Inspect Revenue Open source 2003-07-01 – 2004-06-30: 35826000 USD Inspect Net Income Open source 2003-07-01 – 2004-06-30: 25753000 USD Inspect Operating Cash Flow Open source 2003-07-01 – 2004-06-30: 530000 USD Inspect Capital Expenditure Open source
2005 2004-07-01 – 2005-06-30	160210000	Unavailable	Unavailable	Unavailable	26999000	26406000 Derived	Source 2004-07-01 – 2005-06-30: 160210000 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: 26999000 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: 28137000 USD Inspect Operating Cash Flow Open source 2004-07-01 – 2005-06-30: 1731000 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	239105000	Unavailable	Unavailable	Unavailable	46351000	42940000 Derived	Source 2005-07-01 – 2006-06-30: 239105000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: 46351000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: 49752000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 6812000 USD Inspect Capital Expenditure Open source
2007 2006-07-01 – 2007-06-30	331603000	Unavailable	Unavailable	Unavailable	30529000	-9048000 Derived	Source 2006-07-01 – 2007-06-30: 331603000 USD Inspect Revenue Open source 2006-07-01 – 2007-06-30: 30529000 USD Inspect Net Income Open source 2006-07-01 – 2007-06-30: 6266000 USD Inspect Operating Cash Flow Open source 2006-07-01 – 2007-06-30: 15314000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 331.6M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-06-30	Revenue	14038000	Revenue: 14038000 Open source
20042004-06-30	Revenue	61295000	Revenue: 61295000 Open source
20052005-06-30	Revenue	160210000	Revenue: 160210000 Open source
20062006-06-30	Revenue	239105000	Revenue: 239105000 Open source
20072007-06-30	Revenue	331603000	Revenue: 331603000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

38.7% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-06-30	Year over year	No prior comparable period	Revenue: 14038000 Open source
20042004-06-30	Year over year	336.6%	Revenue: 61295000 Open source Revenue: 14038000 Open source
20052005-06-30	Year over year	161.4%	Revenue: 160210000 Open source Revenue: 61295000 Open source
20062006-06-30	Year over year	49.2%	Revenue: 239105000 Open source Revenue: 160210000 Open source
20072007-06-30	Year over year	38.7%	Revenue: 331603000 Open source Revenue: 239105000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin 9.2% 2007

Free cash flow margin -2.7% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2003-06-30	Operating margin	Not reported	Revenue: 14038000 Open source
2004-06-30	Operating margin	Not reported	Revenue: 61295000 Open source
2005-06-30	Operating margin	Not reported	Revenue: 160210000 Open source
2006-06-30	Operating margin	Not reported	Revenue: 239105000 Open source
2007-06-30	Operating margin	Not reported	Revenue: 331603000 Open source
20032003-06-30	Net margin	-161.3%	Net Income: -22638000 Open source Revenue: 14038000 Open source
20042004-06-30	Net margin	58.4%	Net Income: 35826000 Open source Revenue: 61295000 Open source
20052005-06-30	Net margin	16.9%	Net Income: 26999000 Open source Revenue: 160210000 Open source
20062006-06-30	Net margin	19.4%	Net Income: 46351000 Open source Revenue: 239105000 Open source
20072007-06-30	Net margin	9.2%	Net Income: 30529000 Open source Revenue: 331603000 Open source
20032003-06-30	Free cash flow margin	-99.8%	Revenue: 14038000 Open source Operating Cash Flow: -13614000 Open source Capital Expenditure: 402000 Open source
20042004-06-30	Free cash flow margin	41.2%	Revenue: 61295000 Open source Operating Cash Flow: 25753000 Open source Capital Expenditure: 530000 Open source
20052005-06-30	Free cash flow margin	16.5%	Revenue: 160210000 Open source Operating Cash Flow: 28137000 Open source Capital Expenditure: 1731000 Open source
20062006-06-30	Free cash flow margin	18%	Revenue: 239105000 Open source Operating Cash Flow: 49752000 Open source Capital Expenditure: 6812000 Open source
20072007-06-30	Free cash flow margin	-2.7%	Revenue: 331603000 Open source Operating Cash Flow: 6266000 Open source Capital Expenditure: 15314000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 6.3M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-06-30	Operating cash flow	-13614000	Operating Cash Flow: -13614000 Open source
20042004-06-30	Operating cash flow	25753000	Operating Cash Flow: 25753000 Open source
20052005-06-30	Operating cash flow	28137000	Operating Cash Flow: 28137000 Open source
20062006-06-30	Operating cash flow	49752000	Operating Cash Flow: 49752000 Open source
20072007-06-30	Operating cash flow	6266000	Operating Cash Flow: 6266000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-06-30	Free cash flow	-14016000	Operating Cash Flow: -13614000 Open source Capital Expenditure: 402000 Open source
20042004-06-30	Free cash flow	25223000	Operating Cash Flow: 25753000 Open source Capital Expenditure: 530000 Open source
20052005-06-30	Free cash flow	26406000	Operating Cash Flow: 28137000 Open source Capital Expenditure: 1731000 Open source
20062006-06-30	Free cash flow	42940000	Operating Cash Flow: 49752000 Open source Capital Expenditure: 6812000 Open source
20072007-06-30	Free cash flow	-9048000	Operating Cash Flow: 6266000 Open source Capital Expenditure: 15314000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

13.6% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-06-30	Liabilities / assets	Not reported	No source recorded
20042004-06-30	Liabilities / assets	24.2%	Total Liabilities: 17181000 Open source Total Assets: 71035000 Open source
20052005-06-30	Liabilities / assets	32.9%	Total Liabilities: 21010000 Open source Total Assets: 63840000 Open source
20062006-06-30	Liabilities / assets	13.9%	Total Liabilities: 35822000 Open source Total Assets: 258095000 Open source
20072007-06-30	Liabilities / assets	13.6%	Total Liabilities: 43403000 Open source Total Assets: 318751000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.01× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2003-06-30	Current assets / current liabilities	Not reported	No source recorded
20042004-06-30	Current assets / current liabilities	4.26×	Current Assets: 61601000 Open source Current Liabilities: 14450000 Open source
20052005-06-30	Current assets / current liabilities	2.75×	Current Assets: 51465000 Open source Current Liabilities: 18729000 Open source
20062006-06-30	Current assets / current liabilities	3.16×	Current Assets: 106682000 Open source Current Liabilities: 33812000 Open source
20072007-06-30	Current assets / current liabilities	4.01×	Current Assets: 163854000 Open source Current Liabilities: 40863000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2002-07-01 – 2003-06-30	−USD 22.64 million Exact value Exact value: -22638000 USD 2002-07-01 – 2003-06-30: -22638000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Adams Respiratory Therapeutics, Inc. · 2003-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Net Income: -22638000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: -22638000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950123-05-011561.txt#16517 The citation records this snapshot. The page link may show a newer release later.	−USD 13.61 million Exact value Exact value: -13614000 USD 2002-07-01 – 2003-06-30: -13614000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Adams Respiratory Therapeutics, Inc. · 2003-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Operating Cash Flow: -13614000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13614000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950123-05-011561.txt#16912 The citation records this snapshot. The page link may show a newer release later.	USD 402,000 Exact value Exact value: 402000 USD 2002-07-01 – 2003-06-30: 402000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Adams Respiratory Therapeutics, Inc. · 2003-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Capital Expenditure: 402000 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 402000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950123-05-011561.txt#16950 The citation records this snapshot. The page link may show a newer release later.	−USD 14.02 million Calculation and evidence -13614000 − 402000 USD Exact free cash flow: -14016000 USD 2002-07-01 – 2003-06-30: -13614000 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 402000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Adams Respiratory Therapeutics, Inc. · 2003-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Free cash flow: -14016000 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13614000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950123-05-011561.txt#16912 Input fundies:CapitalExpenditure: 402000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950123-05-011561.txt#16950 The citation records this snapshot. The page link may show a newer release later.
2004 2003-07-01 – 2004-06-30	USD 35.83 million Exact value Exact value: 35826000 USD 2003-07-01 – 2004-06-30: 35826000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Adams Respiratory Therapeutics, Inc. · 2004-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Net Income: 35826000 USD Concept: fundies:NetIncome Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ANetIncome&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:NetIncome: 35826000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-06-009140.txt#18276 The citation records this snapshot. The page link may show a newer release later.	USD 25.75 million Exact value Exact value: 25753000 USD 2003-07-01 – 2004-06-30: 25753000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Adams Respiratory Therapeutics, Inc. · 2004-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Operating Cash Flow: 25753000 USD Concept: fundies:OperatingCashFlow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3AOperatingCashFlow&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25753000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-06-009140.txt#18652 The citation records this snapshot. The page link may show a newer release later.	USD 530,000 Exact value Exact value: 530000 USD 2003-07-01 – 2004-06-30: 530000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Adams Respiratory Therapeutics, Inc. · 2004-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Capital Expenditure: 530000 USD Concept: fundies:CapitalExpenditure Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ACapitalExpenditure&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 530000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-06-009140.txt#18690 The citation records this snapshot. The page link may show a newer release later.	USD 25.22 million Calculation and evidence 25753000 − 530000 USD Exact free cash flow: 25223000 USD 2003-07-01 – 2004-06-30: 25753000 USD · Inspect Operating Cash Flow · Source 2003-07-01 – 2004-06-30: 530000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Adams Respiratory Therapeutics, Inc. · 2004-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Free cash flow: 25223000 USD Concept: free-cash-flow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25753000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-06-009140.txt#18652 Input fundies:CapitalExpenditure: 530000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-06-009140.txt#18690 The citation records this snapshot. The page link may show a newer release later.
2005 2004-07-01 – 2005-06-30	USD 27 million Exact value Exact value: 26999000 USD 2004-07-01 – 2005-06-30: 26999000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Adams Respiratory Therapeutics, Inc. · 2005-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Net Income: 26999000 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: 26999000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#31681 The citation records this snapshot. The page link may show a newer release later.	USD 28.14 million Exact value Exact value: 28137000 USD 2004-07-01 – 2005-06-30: 28137000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Adams Respiratory Therapeutics, Inc. · 2005-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Operating Cash Flow: 28137000 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 28137000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 The citation records this snapshot. The page link may show a newer release later.	USD 1.73 million Exact value Exact value: 1731000 USD 2004-07-01 – 2005-06-30: 1731000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Adams Respiratory Therapeutics, Inc. · 2005-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Capital Expenditure: 1731000 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1731000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.	USD 26.41 million Calculation and evidence 28137000 − 1731000 USD Exact free cash flow: 26406000 USD 2004-07-01 – 2005-06-30: 28137000 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 1731000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Adams Respiratory Therapeutics, Inc. · 2005-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Free cash flow: 26406000 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 28137000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 Input fundies:CapitalExpenditure: 1731000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	USD 46.35 million Exact value Exact value: 46351000 USD 2005-07-01 – 2006-06-30: 46351000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Adams Respiratory Therapeutics, Inc. · 2006-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Net Income: 46351000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: 46351000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#31681 The citation records this snapshot. The page link may show a newer release later.	USD 49.75 million Exact value Exact value: 49752000 USD 2005-07-01 – 2006-06-30: 49752000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Adams Respiratory Therapeutics, Inc. · 2006-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Operating Cash Flow: 49752000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 49752000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 The citation records this snapshot. The page link may show a newer release later.	USD 6.81 million Exact value Exact value: 6812000 USD 2005-07-01 – 2006-06-30: 6812000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Adams Respiratory Therapeutics, Inc. · 2006-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Capital Expenditure: 6812000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6812000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.	USD 42.94 million Calculation and evidence 49752000 − 6812000 USD Exact free cash flow: 42940000 USD 2005-07-01 – 2006-06-30: 49752000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 6812000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Adams Respiratory Therapeutics, Inc. · 2006-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Free cash flow: 42940000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 49752000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 Input fundies:CapitalExpenditure: 6812000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.
2007 2006-07-01 – 2007-06-30	USD 30.53 million Exact value Exact value: 30529000 USD 2006-07-01 – 2007-06-30: 30529000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Net Income: 30529000 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: 30529000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#31681 The citation records this snapshot. The page link may show a newer release later.	USD 6.27 million Exact value Exact value: 6266000 USD 2006-07-01 – 2007-06-30: 6266000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Operating Cash Flow: 6266000 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6266000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 The citation records this snapshot. The page link may show a newer release later.	USD 15.31 million Exact value Exact value: 15314000 USD 2006-07-01 – 2007-06-30: 15314000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Capital Expenditure: 15314000 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15314000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.	−USD 9.05 million Calculation and evidence 6266000 − 15314000 USD Exact free cash flow: -9048000 USD 2006-07-01 – 2007-06-30: 6266000 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 15314000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Adams Respiratory Therapeutics, Inc. · 2007-06-30 Adams Respiratory Therapeutics, Inc. (edgar:1319439) Free cash flow: -9048000 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-05T03:20:13Z Snapshot: bf5e4f691511c1d8b894a983a0a174c40e4166e7acce3c666a43bbd1e8079129 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1319439?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6266000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32477 Input fundies:CapitalExpenditure: 15314000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1319439/0000950144-07-008258.txt#32564 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-05. Source filing dates and reporting periods are shown separately.

Identifiers: 0001319439, 1319439, edgar:1319439

Also known as Adams Laboratories, Inc.

Adams Respiratory Therapeutics, Inc.

Latest quarter

Revenue

Net margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2006-07-01 – 2007-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation